White Paper
Telemedicine and AI
Strengths and Limitations of Telemedicine and AI solutions
People with diabetes should have an annual or biannual diabetic retinal exam, but many health systems report 50% compliance or less for this important quality metric.
We know there is a significant problem with diabetic retinopathy exam compliance rates, yet many health systems struggle to find solutions that address this gap in care. Now, with point-of-care diabetic retinopathy detection we can remove barriers to access and help more people complete their exam.
Read this white paper on testing for diabetic retinopathy in primary care
This white paper will help you understand the strengths and limitations of currently available options so you can successfully begin testing patients for diabetic retinopathy in primary care.
Learn about the following:
-
Challenges to diabetic retinopathy exam compliance
-
Advantages/disadvantages of using telemedicine to assess for diabetic retinopathy
-
Questions to ask when assessing telemedicine options
-
How to separate real AI solutions from the hype
Testing for Diabetic Retinopathy in Primary Care White Paper
Notice: The content embedded within PDF files on this website ("Content") is provided solely for educational purposes. Digital Diagnostics ("Owner") holds exclusive rights to the Content, including but not limited to copyrights, trademarks, and any other intellectual property rights.